402 related articles for article (PubMed ID: 28350329)
1. Harnessing Solute Carrier Transporters for Precision Oncology.
Nyquist MD; Prasad B; Mostaghel EA
Molecules; 2017 Mar; 22(4):. PubMed ID: 28350329
[TBL] [Abstract][Full Text] [Related]
2. The SLC transporter in nutrient and metabolic sensing, regulation, and drug development.
Zhang Y; Zhang Y; Sun K; Meng Z; Chen L
J Mol Cell Biol; 2019 Jan; 11(1):1-13. PubMed ID: 30239845
[TBL] [Abstract][Full Text] [Related]
3. Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease.
Schumann T; König J; Henke C; Willmes DM; Bornstein SR; Jordan J; Fromm MF; Birkenfeld AL
Pharmacol Rev; 2020 Jan; 72(1):343-379. PubMed ID: 31882442
[TBL] [Abstract][Full Text] [Related]
4. Unraveling 'The Cancer Genome Atlas' information on the role of SLC transporters in anticancer drug uptake.
Al-Abdulla R; Perez-Silva L; Abete L; Romero MR; Briz O; Marin JJG
Expert Rev Clin Pharmacol; 2019 Apr; 12(4):329-341. PubMed ID: 30744443
[TBL] [Abstract][Full Text] [Related]
5. Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers.
Bharadwaj R; Jaiswal S; Velarde de la Cruz EE; Thakare RP
Diseases; 2024 Mar; 12(3):. PubMed ID: 38534987
[TBL] [Abstract][Full Text] [Related]
6. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.
Hushmandi K; Einollahi B; Saadat SH; Lee EHC; Farani MR; Okina E; Huh YS; Nabavi N; Salimimoghadam S; Kumar AP
Mol Metab; 2024 Jun; 84():101952. PubMed ID: 38705513
[TBL] [Abstract][Full Text] [Related]
7. USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2.
Chandrasekaran AP; Kaushal K; Park CH; Kim KS; Ramakrishna S
Theranostics; 2021; 11(20):9752-9771. PubMed ID: 34815782
[No Abstract] [Full Text] [Related]
8. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
Clémençon B; Lüscher BP; Hediger MA
J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
[TBL] [Abstract][Full Text] [Related]
9. Potentiating SLC transporter activity: Emerging drug discovery opportunities.
Rives ML; Javitch JA; Wickenden AD
Biochem Pharmacol; 2017 Jul; 135():1-11. PubMed ID: 28214518
[TBL] [Abstract][Full Text] [Related]
10. Role of
Huang KM; Uddin ME; DiGiacomo D; Lustberg MB; Hu S; Sparreboom A
Expert Opin Drug Metab Toxicol; 2020 Jun; 16(6):493-506. PubMed ID: 32276560
[TBL] [Abstract][Full Text] [Related]
11. Expression analysis of human solute carrier (SLC) family transporters in nasal mucosa and RPMI 2650 cells.
Dolberg AM; Reichl S
Eur J Pharm Sci; 2018 Oct; 123():277-294. PubMed ID: 30041030
[TBL] [Abstract][Full Text] [Related]
12. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.
Schlessinger A; Zatorski N; Hutchinson K; Colas C
Trends Biochem Sci; 2023 Sep; 48(9):801-814. PubMed ID: 37355450
[TBL] [Abstract][Full Text] [Related]
13. Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy-Modulators of Cellular Entry or Pharmacokinetics?
Brecht K; Schäfer AM; Meyer Zu Schwabedissen HE
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32806706
[TBL] [Abstract][Full Text] [Related]
14. Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma.
Marin JJG; Macias RIR; Cives-Losada C; Peleteiro-Vigil A; Herraez E; Lozano E
Cells; 2020 Feb; 9(2):. PubMed ID: 32098199
[TBL] [Abstract][Full Text] [Related]
15. Recent developments in ligands and chemical probes targeting solute carrier transporters.
Casiraghi A; Bensimon A; Superti-Furga G
Curr Opin Chem Biol; 2021 Jun; 62():53-63. PubMed ID: 33689964
[TBL] [Abstract][Full Text] [Related]
16. Overview: Role of Drug Transporters in Drug Disposition and Its Clinical Significance.
Liu X
Adv Exp Med Biol; 2019; 1141():1-12. PubMed ID: 31571163
[TBL] [Abstract][Full Text] [Related]
17. Membrane transporters in cell physiology, cancer metabolism and drug response.
Alam S; Doherty E; Ortega-Prieto P; Arizanova J; Fets L
Dis Model Mech; 2023 Nov; 16(11):. PubMed ID: 38037877
[TBL] [Abstract][Full Text] [Related]
18. ρ⁰ Cells Feature De-Ubiquitination of SLC Transporters and Increased Levels and Fluxes of Amino Acids.
Medina AB; Banaszczak M; Ni Y; Aretz I; Meierhofer D
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28425971
[TBL] [Abstract][Full Text] [Related]
19. Role for Drug Transporters in Chemotherapy-Induced Peripheral Neuropathy.
Stage TB; Hu S; Sparreboom A; Kroetz DL
Clin Transl Sci; 2021 Mar; 14(2):460-467. PubMed ID: 33142018
[TBL] [Abstract][Full Text] [Related]
20. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier.
Mészáros M; Porkoláb G; Kiss L; Pilbat AM; Kóta Z; Kupihár Z; Kéri A; Galbács G; Siklós L; Tóth A; Fülöp L; Csete M; Sipos Á; Hülper P; Sipos P; Páli T; Rákhely G; Szabó-Révész P; Deli MA; Veszelka S
Eur J Pharm Sci; 2018 Oct; 123():228-240. PubMed ID: 30031862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
